AI Terminal
Taylor Wimpey PLC
Director's Dealing • Dec 4, 2024
5247_dirs_2024-12-04_28d80a34-8574-424d-a48e-a5117fe27d4e.html
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 8609O
Taylor Wimpey PLC
04 December 2024
4 December 2024
Taylor Wimpey plc
Director / PDMR Shareholding
Taylor Wimpey plc (the "Company") has been advised by Apex Group Limited, in its capacity as Trustee of the Company's Employee Benefit Trust (the "Trust") that, as a result of participation by the Trust in the Company's Dividend Reinvestment Plan ("DRIP") in respect of the 2024 Interim Dividend paid by the Company on 15 November 2024, the following number of ordinary shares in the Company have been acquired by the Trust and are held on trust on behalf of the Directors named below:
| Director | Number of Shares purchased | Price per Share | Date of Transaction |
| Jennie Daly | 16,915 | £1.310294 | 28 November 2024 |
| Chris Carney | 15,265 | £1.310294 | 28 November 2024 |
In accordance with Article 19 of the UK Market Abuse Regulation, detailed information is set out below.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Jennie Daly
2
Reason for the notification
a)
Position/status
Chief Executive
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Taylor Wimpey plc
b)
LEI
21380089BTRXTD8S3R66
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 1 pence each
GB0008782301
b)
Nature of the transaction
Purchase of Ordinary 1p shares in the Company by the Company's Employee Benefit Trust pursuant to the terms of the Company's Dividend Reinvestment Plan, following the payment of a dividend on 15 November 2024
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £1.310294 | 16,915 |
d)
Aggregated information
- Aggregated volume
- Price
16,915 shares
£1.310294
e)
Date of the transaction
28 November 2024
f)
Place of the transaction
London Stock Exchange (XLON)
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Chris Carney
2
Reason for the notification
a)
Position/status
Group Finance Director
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Taylor Wimpey plc
b)
LEI
21380089BTRXTD8S3R66
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 1 pence each
GB0008782301
b)
Nature of the transaction
Purchase of Ordinary 1p shares in the Company by the Company's Employee Benefit Trust pursuant to the terms of the Company's Dividend Reinvestment Plan, following the payment of a dividend on 15 November 2024
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £1.310294 | 15,265 |
d)
Aggregated information
- Aggregated volume
- Price
15,265 shares
£1.310294
e)
Date of the transaction
28 November 2024
f)
Place of the transaction
London Stock Exchange (XLON)
For further information please contact:
Taylor Wimpey plc
Mike Lonnon, Deputy Company Secretary Tel: +44 (0) 1494 885 616
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFSAFWLELSESE